Palvella Therapeutics, Inc. (PVLA)
NASDAQ: PVLA · Real-Time Price · USD
125.96
-2.68 (-2.08%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Palvella Therapeutics Market Cap
Palvella Therapeutics has a market cap or net worth of $1.80 billion as of April 29, 2026. Its market cap has increased by 651.96% in one year.
Market Cap
1.80B
Enterprise Value
1.76B
1-Year Change
651.96%
Ranking
Category
Stock Price
$125.96
Market Cap Chart
Since December 16, 2024, Palvella Therapeutics's market cap has increased from $143.97M to $1.80B, an increase of 1,152.31%. That is a compound annual growth rate of 537.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 1.80B | 45.53% |
| Dec 31, 2025 | 1.24B | 820.07% |
| Dec 31, 2024 | 134.66M | -6.47% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Inhibrx Biosciences | 1.92B |
| AnaptysBio | 1.91B |
| Galapagos NV | 1.89B |
| Vericel | 1.88B |
| Pharvaris | 1.88B |
| Taysha Gene Therapies | 1.86B |
| Syndax Pharmaceuticals | 1.85B |
| Recursion Pharmaceuticals | 1.84B |